Compare Bio Protocol (BIO) vs GT Protocol (GTAI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bio Protocol vs GT Protocol — how do they compare? Bio Protocol trades at Rp497.8 (market cap Rp1,12T, Rp283,83M 24h volume), while GT Protocol trades at Rp143.85 (market cap Rp9,93M, Rp3,45M 24h volume). The key difference: Bio Protocol is far larger — about 112789.5× GT Protocol's market cap, and Bio Protocol's circulating supply is 2,2B / 3,3B BIO (68%) versus 68,8M / 75M GTAI (92%) for GT Protocol. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 16 Days and GT Protocol for 16 Days on average.
| BIO | GTAI | |
|---|---|---|
Market Cap | Rp1,12T | Rp9,93M |
Volume (24h) | Rp283,83M | Rp3,45M |
Circulating Supply | 2,2B / 3,3B BIO (68%) | 68,8M / 75M GTAI (92%) |
Typical Hold Time | 16 Days | 16 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Bio Protocol (BIO) trades at Rp514.67 with a market cap of Rp1.15 trillion, showing a bearish technical signal as moving averages indicate selling pressure. The token's circulating supply is 2.2 million out of 3.3 million, with a 68% circulation rate and average hold time of 16 days. Recent news highlights participation in blockchain and tech events, though no major protocol upgrades were reported in the last month.
Overall outlook remains cautious due to bearish technicals and neutral oscillators. Key opportunities include potential rebound from oversold RSI levels near support at Rp474. Major risks involve low liquidity, regulatory uncertainty in Indonesia, and high volatility typical of small-cap cryptocurrencies.
GT Protocol (GTAI) is trading at Rp143.43 with a market cap of Rp9.96M, exhibiting a bearish technical signal overall despite bullish oscillators. The asset is near support at S2 (Rp145) and S3 (Rp131), with resistance at R1 (Rp174). Circulating supply is 68.8 million out of 75 million GTAI, with a 92% circulation rate and average hold time of 16 days. No major protocol updates or ecosystem news are available.
Outlook is cautious due to bearish momentum and limited liquidity. Opportunities include potential rebounds from oversold RSI levels, but risks include low market cap volatility, regulatory uncertainty, and thin trading volumes. Investors should monitor for network growth and exchange listings.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Bio Protocol
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →About GT Protocol
The GT Protocol features a strong ecosystem that combines an investment protocol for decentralized Web3 fund management with Blockchain AI Execution Technology, all accessible through the GT API SDK. This ecosystem includes the GT APP, a Web3 investment platform that has already gained 70,000 registered users. It has achieved significant milestones, such as becoming an official broker for the Binance exchange and establishing a partnership with the TRON blockchain.
Read more on GTAI →
